Cancer Therapeutics CRC

About Cancer Therapeutics CRC

Cancer Therapeutics CRC (CTx) is in the business of finding cures for cancer. It was founded in 2007 and received an initial seven years of funding from the Cooperative Research Centre (CRC) Programme. It is a collaborative partnership of leading research institutes, universities and biotechnology companies, that translates Australia’s innovative research discoveries into new cancer drugs ready for clinical development. CTx was awarded a further six years of CRC Programme funding from July 2014. In addition to the CRC Programme funding CTx receives licensing revenues and additional cash and in-kind funding from its 17 partners.